Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-14.57%
operating margin TTM
-4.83%
revenue TTM
114.63 Million
revenue per share TTM
2.63$
valuation ratios | |
|---|---|
| pe ratio | -2.51 |
| peg ratio | 0.08 |
| price to book ratio | 0.55 |
| price to sales ratio | 0.37 |
| enterprise value multiple | 1.56 |
| price fair value | 0.55 |
profitability ratios | |
|---|---|
| gross profit margin | 54.26% |
| operating profit margin | -4.83% |
| pretax profit margin | -13.67% |
| net profit margin | -14.57% |
| return on assets | -10.85% |
| return on equity | -20.76% |
| return on capital employed | -4.36% |
liquidity ratio | |
|---|---|
| current ratio | 2.06 |
| quick ratio | 0.91 |
| cash ratio | 0.20 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 212.21 |
| operating cycle | 260.13 |
| days of payables outstanding | 43.14 |
| cash conversion cycle | 216.99 |
| receivables turnover | 7.62 |
| payables turnover | 8.46 |
| inventory turnover | 1.72 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.35 |
| debt equity ratio | 0.70 |
| long term debt to capitalization | 0.34 |
| total debt to capitalization | 0.41 |
| interest coverage | -1.50 |
| cash flow to debt ratio | 0.09 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.01 |
| cash per share | 0.10 |
| operating cash flow per share | 0.09 |
| free cash flow operating cash flow ratio | 0.15 |
| cash flow coverage ratios | 0.09 |
| short term coverage ratios | 1.11 |
| capital expenditure coverage ratio | 1.18 |
Frequently Asked Questions
When was the last time Harvard Bioscience, Inc. (NASDAQ:HBIO) reported earnings?
Harvard Bioscience, Inc. (HBIO) published its most recent earnings results on 08-11-2024.
What is Harvard Bioscience, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Harvard Bioscience, Inc. (NASDAQ:HBIO)'s trailing twelve months ROE is -20.76%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Harvard Bioscience, Inc. (HBIO) currently has a ROA of -10.85%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HBIO's net profit margin stand at?
HBIO reported a profit margin of -14.57% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HBIO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.06 in the most recent quarter. The quick ratio stood at 0.91, with a Debt/Eq ratio of 0.70.